Drug Shortage Report for TEVA-PROCTOSONE
| Report ID | 88222 |
| Drug Identification Number | 02226383 |
| Brand name | TEVA-PROCTOSONE |
| Common or Proper name | PROCTOSONE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN |
| Strength(s) | 5MG 5MG 10MG 10MG |
| Dosage form(s) | OINTMENT |
| Route of administration | RECTAL |
| Packaging size | 15G |
| ATC code | C05AA |
| ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2020-07-02 |
| Estimated end date | Unknown |
| Actual end date | 2025-04-07 |
| Shortage status | Resolved |
| Updated date | 2025-04-25 |
| Company comments | Discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v17 | 2025-04-25 | French | Compare |
| v16 | 2025-04-25 | English | Compare |
| v15 | 2021-01-14 | French | Compare |
| v14 | 2021-01-14 | English | Compare |
| v13 | 2019-12-19 | French | Compare |
| v12 | 2019-12-19 | English | Compare |
| v11 | 2019-12-12 | French | Compare |
| v10 | 2019-12-12 | English | Compare |
| v9 | 2019-10-03 | French | Compare |
| v8 | 2019-10-03 | English | Compare |
| v7 | 2019-09-05 | French | Compare |
| v6 | 2019-09-05 | English | Compare |
| v5 | 2019-08-29 | French | Compare |
| v4 | 2019-08-29 | English | Compare |
| v3 | 2019-07-03 | English | Compare |
| v2 | 2019-07-02 | French | Compare |
| v1 | 2019-07-02 | English | Compare |
Showing 1 to 17 of 17